Detalhe da pesquisa
1.
Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK140944).
BMC Microbiol
; 21(1): 181, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34130619
2.
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.
N Engl J Med
; 370(3): 211-21, 2014 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24428467
3.
Correction to: Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK2140944).
BMC Microbiol
; 21(1): 293, 2021 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34702186
4.
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients.
Liver Int
; 36(2): 189-97, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26473667
5.
Preliminary study of two antiviral agents for hepatitis C genotype 1.
N Engl J Med
; 366(3): 216-24, 2012 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22256805
6.
Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.
Gastroenterology
; 146(2): 420-9, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24184132
7.
Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders.
J Hepatol
; 60(3): 490-9, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24444658
8.
Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches.
PLoS One
; 16(11): e0259731, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34843493
9.
A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection.
J Hepatol
; 62(5): 1204-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25559328
10.
Pharmacokinetics, Safety, and Tolerability Evaluation of Single and Multiple Doses of GSK3342830 in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 8(6): 754-764, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536589
11.
An unusual cause of ST segment elevation. Brugada syndrome.
Clin Infect Dis
; 42(6): 826-7, 885-6, 2006 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16479680
12.
CD40L-containing virus-like particle as a candidate HIV-1 vaccine targeting dendritic cells.
J Acquir Immune Defic Syndr
; 56(5): 393-400, 2011 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21239998
13.
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers.
PLoS One
; 6(5): e19252, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21603651
14.
Decreasing in vitro susceptibility of clinical Staphylococcus aureus isolates to vancomycin at the New York Hospital: quantitative testing redux.
Clin Infect Dis
; 40(11): 1705-6, 2005 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15889380
15.
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.
PLoS One
; 5(1): e8816, 2010 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20111599
16.
Clinical relevance of bacteriostatic versus bactericidal activity in the treatment of gram-positive bacterial infections.
Clin Infect Dis
; 39(5): 755-6, 2004 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15356797
17.
A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.
Vaccine
; 27(27): 3598-604, 2009 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19464540
18.
Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant.
J Acquir Immune Defic Syndr
; 47(4): 403-11, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18209683
19.
Multiple-site DNA vaccination enhances immune responses in mice.
Vaccine
; 24(3): 287-92, 2006 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-16137804